Dr. Ramzi Abboud, M.D.
Claim this profileWashington University School of Medicine
Studies Leukemia
Studies Myeloid Leukemia
11 reported clinical trials
24 drugs studied
Area of expertise
1Leukemia
HLA-A negative
HLA-A positive
HLA positive
2Myeloid Leukemia
HLA-A negative
HLA-A positive
HLA positive
Affiliated Hospitals
Clinical Trials Ramzi Abboud, M.D. is currently running
Stem Cell Transplantation
for Leukemia
This is a prospective, multi-center, Phase II study of hematopoietic cell transplantation (HCT) using human leukocyte antigen (HLA)-mismatched unrelated donors (MMUD) for peripheral blood stem cell transplant in adults and bone marrow stem cell transplant in children. Post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate mofetil (MMF) will be used for for graft versus host disease (GVHD) prophylaxis. This trial will study how well this treatment works in patients with hematologic malignancies.
Recruiting1 award Phase 2
Inotuzumab Ozogamicin + Chemotherapy
for Leukemia and Lymphoma
This trial tests a new treatment combining inotuzumab ozogamicin with chemotherapy for patients with certain types of blood cancer. The new drug targets cancer cells directly and delivers a toxin to kill them. This approach aims to improve the effectiveness of treatment compared to standard chemotherapy alone. Inotuzumab ozogamicin has shown superior efficacy compared to conventional chemotherapy in patients with specific types of blood cancer.
Recruiting3 awards Phase 2
More about Ramzi Abboud, M.D.
Clinical Trial Related2 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Ramzi Abboud, M.D. has experience with
- Venetoclax
- Azacitidine
- Cyclophosphamide
- Fludarabine
- Cytarabine
- Daunorubicin Hydrochloride
Breakdown of trials Ramzi Abboud, M.D. has run
Leukemia
Myeloid Leukemia
Acute Myeloid Leukemia
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ramzi Abboud, M.D. specialize in?
Ramzi Abboud, M.D. focuses on Leukemia and Myeloid Leukemia. In particular, much of their work with Leukemia has involved HLA-A negative patients, or patients who are HLA-A positive.
Is Ramzi Abboud, M.D. currently recruiting for clinical trials?
Yes, Ramzi Abboud, M.D. is currently recruiting for 8 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Ramzi Abboud, M.D. has studied deeply?
Yes, Ramzi Abboud, M.D. has studied treatments such as Venetoclax, Azacitidine, Cyclophosphamide.
What is the best way to schedule an appointment with Ramzi Abboud, M.D.?
Apply for one of the trials that Ramzi Abboud, M.D. is conducting.
What is the office address of Ramzi Abboud, M.D.?
The office of Ramzi Abboud, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.